EverSource Wealth Advisors’s Tenax Therapeutics TENX Stock Holding History

EverSource Wealth Advisors’s Portfolio TENX Stock Details TENX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$3.55K	Buy	+1,877	New	+$14.1K	﹤0.01%	3486

Other funds holding TENX

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

Caitong International Asset Management Hong Kong $1.04B AUM 150.26% 1-Year Est. Return

UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return

Citigroup New York $308B AUM 40.94% 1-Year Est. Return

Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

State of Alaska Department of Revenue Juneau, Alaska $9.6B AUM 34.67% 1-Year Est. Return

EverSource Wealth Advisors's TENX Position: Q3 2026 in Review

EverSource Wealth Advisors opened a new position in Tenax Therapeutics (TENX) in Q3 2026: 1,877 shares worth $3.55K. The stake represents ﹤0.01% of the portfolio and ranks #3486 among its holdings.

36 funds tracked by Wall St. Rank hold TENX as of Q3 2026.

EverSource Wealth Advisors held 1,877 shares of Tenax Therapeutics worth $3.55K as of Q3 2026.
Tenax Therapeutics was a new EverSource Wealth Advisors position in Q3 2026.
Tenax Therapeutics made up ﹤0.01% of EverSource Wealth Advisors's portfolio in Q3 2026, its #3486 holding.
36 funds tracked by Wall St. Rank held Tenax Therapeutics as of Q3 2026.

Based on EverSource Wealth Advisors's 13F filing for Q3 2026, filed 4 Nov 2026.